|
(b)(4).Date sent: 11/9/2021.Additional information was requested and the following was obtained: the distribution center this complaint was reported from is a jnj distribution center.The product was still under jnj control.Investigation summary the product was returned to ethicon endo surgery for evaluation.Visual inspection was conducted on the returned device.The nslg2s45 device d was returned inside its original packaging.Upon visual inspection, it was noted that the outer label from a shipping box, the lot can be observed as r93p1k, and the label from the internal box and the tyvek a lot can be observed as r93g48.A manufacturing record evaluation was performed for the finished device batch number, and no non-conformances were identified.As part of ethicon endo surgery quality process all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of post market surveillance.Further investigation on the complaint a manufacturing issue was found at jabil facilities, an nr was initiated to documented it.Upon review of the information provided, it was concluded that this event does not meet the fda defined criteria for a reportable event and is being considered not reportable.
|